Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care

Tiffaney Tran, Peggy R. Cyr, Alex Verdieck, Miranda D. Lu, Hadjh T. Ahrns, Elizabeth G. Berry, William Bowen, Ralph P. Braun, Joshua M. Cusick-Lewis, Hung Q. Doan, Valerie L. Donohue, Deborah R. Erlich, Laura K. Ferris, Evelyne Harkemanne, Rebecca I. Hartman, James Holt, Natalia Jaimes, Timothy A. Joslin, Zhyldyz Kabaeva, Tracey N. Liebman, Joanna Ludzik, Ashfaq A. Marghoob, Isac Simpson, Jennifer A. Stein, Daniel L. Stulberg, Isabelle Tromme, Matthew J. Turnquist, Richard P. Usatine, Alison M. Walker, Bryan L. Walker, Robert F. West, Megan L. Wilson, Alexander Witkowski, Dominic J. Wu, Elizabeth V. Seiverling and Kelly C. Nelson
The Journal of the American Board of Family Medicine February 2023, 36 (1) 25-38; DOI: https://doi.org/10.3122/jabfm.2022.220143R1
Tiffaney Tran
From the Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston (TT, HQD, KCN); Department of Family Medicine, Maine Medical Center, Portland (PRC, HTA); Department of Family Medicine, Tufts University School of Medicine, Boston, MA (PRC, DRE); Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland (AV, TAJ); Swedish First Hill Family Medicine Residency, Seattle, WA (MDL); Department of Dermatology, Oregon Health & Science University School of Medicine, Portland (EGB, JL, AW); Christus St. Vincent Family Medicine Center, Sante Fe, NM (WB); Department of Dermatology, University Hospital of Zürich, University of Zürich, Zürich, Switzerland (RPB); Cabin Creek Health Systems, Dawes, WV (JMC-L); Lincoln Medical Partners, Damariscotta, ME (VLD); Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA (LKF); Dermatology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium (EH); Institute of Experimental & Clinical Research, Université Catholique de Louvain, Brussels, Belgium (EH); Department of Dermatology, Brigham and Women's Hospital, Boston, MA (RIH); Melanoma Program, Dana-Farber Cancer Institute, Boston, MA (RIH); Veterans Integrated Services Network, Jamaica Plain, MA (RIH); Department of Family Medicine, East Tennessee State University James H. Quillen College of Medicine, Johnson City, TN (JH); Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL (NJ); Sylvester Comprehensive Cancer Center, Miami, FL (NJ); Department of Internal Medicine, Maine Medical Center, Cape Elizabeth, ME (ZK); The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York (TNL, JAS); Department of Telemedicine and Bioinformatics, Jagiellonian University Medical College, Krakow, Poland (JL); Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY (AAM); Simpson DermCare & Family Medicine, Ammon, ID (IS); Department of Family & Community Medicine, University of New Mexico School of Medicine, Albuquerque (DLS); Dermatology Department, King Albert II Cancer and Hematology Institute, Cliniques Universitaires Saint-Luc, Brussels, Belgium (IT); Department of Family Medicine, Millinocket Regional Hospital, Millinocket, ME (MJT); Western Maine Primary Care, Norway (MJT); Department of Dermatology & Cutaneous Surgery, Department of Family & Community Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU); Brigham and Women's Health Care Center, Pembroke, MA (AMW); South Shore Medical Center, Norwell, MA (BLW); Redirect Health, Glendale, AZ (RFW); Department of Family Medicine, University of Washington School of Medicine, Seattle (MLW); Department of Dermatology, University of Kansas Medical Center, Kansas City (DJW); Division of Dermatology, Maine Medical Center, Portland (EVS); Department of Dermatology, Tufts University School of Medicine, Boston, MA (EVS)
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggy R. Cyr
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Verdieck
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miranda D. Lu
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hadjh T. Ahrns
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth G. Berry
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Bowen
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph P. Braun
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua M. Cusick-Lewis
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hung Q. Doan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie L. Donohue
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah R. Erlich
MD, MMedEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura K. Ferris
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evelyne Harkemanne
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca I. Hartman
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Holt
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Jaimes
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy A. Joslin
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhyldyz Kabaeva
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracey N. Liebman
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Ludzik
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashfaq A. Marghoob
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isac Simpson
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A. Stein
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel L. Stulberg
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Tromme
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. Turnquist
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard P. Usatine
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison M. Walker
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan L. Walker
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. West
MD, MMed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan L. Wilson
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Witkowski
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominic J. Wu
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth V. Seiverling
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly C. Nelson
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Consensus process using a 2-phase modified Delphi method.

Tables

  • Figures
    • View popup
    Table 1.

    Demographic Characteristics of Larger Expert Panel (n = 35 Participants in First Round)

    Specialty (n = 35)Count%
    Family medicine1954.3%
    Internal medicine25.7%
    Medicine—pediatrics00.0%
    Dermatology1440.0%
    Other00.0%
    Dermoscopy use in clinical practice (n = 35)Count%
    Yes35100%
    No00.0%
    No. years of dermoscopy use in clinical practice (n = 35)Count%
    0 to 1 year00.0%
    1 to 5 years1645.7%
    6 to 10 years1028.6%
    11 to 15 years411.4%
    15 + years514.3%
    Specialization in pigmented lesions, dermoscopy, or melanoma as an attending physician (n = 35)Count%
    Yes1645.7%
    No1954.3%
    No. years of specialization in pigmented lesions, dermoscopy, or melanoma as an attending physician (n = 16)Count%
    0 to 1 year00.0%
    1 to 5 years743.8%
    6 to 10 years212.5%
    11 to 15 years425.0%
    15 + years318.8%
    Direct involvement in dermoscopy training for primary care (n = 35)Count%
    Yes2262.9%
    No1337.1%
    If directly involved in dermoscopy training for primary care, type of training offered* (n = 22)Count%
    Dermoscopy training in clinic1881.8%
    Dermoscopy training in a lecture format1568.2%
    Other†313.6%
    • ↵* Multiple selections allowed, sum of percentages >100%.

    • ↵† Other delivery methods for dermoscopy training, as reported by panelists, included virtual training, e-learning, distance learning.

    • View popup
    Table 2.

    Dermoscopic Diagnoses by Lesion Category and Proficiency Standard

    CategoryLevel 1 (Foundational)Level 2 (Intermediate)Neither
    Nonmelanocytic lesions
    • Hemangioma

    • Sebaceous hyperplasia

    • Clear cell acanthoma

    • Seborrheic keratosis

    • Pigmented actinic keratosis

    • Merkel cell carcinoma†

    • Dermatofibroma

    • Squamous cell carcinoma in situ

    • Porokeratosois†

    • Solar lentigo

    • Keratoacanthoma

    • Poroma‡

    • Basal cell carcinoma

    • Angiokeratoma

    • Xanthogranuloma‡

    • Squamous cell carcinoma

    • Lichen planus-like keratosis

    • Actinic keratosis

    • Ink spot lentigo†

    Benign melanocytic lesions
    • Overview of benign nevi patterns

    • Blue nevi

    • Combined nevi†

    • Intradermal nevi

    • Spitz nevi

    • Congenital melanocytic nevi

    • Recurrent/persistent nevi

    • Halo nevi†

    Melanoma
    • Overview of melanoma patterns

    • Acral melanoma

    • Desmoplastic melanoma†

    • Lentigo maligna melanoma

    • Nevoid melanoma†

    • Melanoma of the nail

    • Verrucous melanoma†

    • Amelanotic/hypomelanotic melanoma

    Special sitesSubungual hemorrhage
    • Dermoscopic features of the face

    • Nevi of the mucosa†

    • Benign patterns of acral nevi

    • Nevi of the mucocutaneous junction†

    • Nevus of the nail

    • Lentigo of the nail

    • Talon noir†

    Other
    • Verruca*

    • Molluscum contagiosum*

    • Atopic dermatitis†

    • Scabies

    • Radiation tattoo*

    • Scars*

    • Venous lake*

    • Psoriasis†

    • ↵* Suggested by the expert focus group to add onto the Melanoma Prevention Working Group-Pigmented Lesions Subcommittee consensus-based list for dermatology residents.

    • ↵† Suggested by a panelist during round 1 of the diagnoses survey series.

    • ↵‡ Suggested by a panelist during round 2 of the diagnoses survey series.

    • View popup
    Table 3.

    Dermoscopic Characteristics of Nonmelanocytic Lesions

    Diagnosis (Level 1 or 2)
    Feature included as a learning objective (>70% positive responses)
    Round 1: % Positive Responses* (n = 33)Round 2: % Positive Responses* (n = 30)
    Hemangioma (level 1)
     Red, blue-red, red-purple, or maroon lacunae/lagoons with white septae72.7%—
     Blue-black coloring in lacunae (when thrombosed) in absence of other structures72.7%—
    Seborrheic keratosis (level 1)
     Milia-like cysts (cloudy or starry) and comedo-like openings93.9%—
     “Fissures and ridges”/“gyri and sulci”/cerebriform pattern93.9%—
     Moth-eaten (sharply demarcated) borders87.9%—
     Fat fingers78.8%—
     Fingerprint-like structures (parallel lines)78.8%—
     Hairpin (looped) vessels78.8%—
    Dermatofibroma (level 1)
     Central scar-like white patch/depigmentation100.0%—
     Fine/delicate surrounding/peripheral network-like structures100.0%—
     Central shiny white lines/streaks under polarized dermoscopy84.8%—
     Ring-like globules66.7%↓ 60.0%
    Solar lentigo (level 1)
     Moth-eaten (sharply demarcated) borders90.9%—
     Fingerprint-like structures (parallel lines)90.9%—
     Homogenous light brown pigmentation87.9%—
     Uniform brown perifollicular pigmentation75.8%—
     Network-like structures63.6%↓ 63.3%
    Basal cell carcinoma (level 1)
     Arborizing vessels97.0%—
     Ulceration/erosion93.9%—
     Leaf-like structures/areas90.9%—
     Blue-gray ovoid nests87.9%—
     Spoke-wheel-like structures/areas/concentric structures87.9%—
     Multiple blue-gray dots and globules (buckshot scatter)84.8%—
     Shiny white blotches and strands/structures under polarized dermoscopy69.7%↑ 76.7%
     Short fine telangiectasias (superficial BCC)69.7%↑ 70.0%
    Squamous cell carcinoma (level 1)
     Yellow keratin mass/scale-crust100.0%—
     Ulceration/blood spots/hemorrhage93.9%—
     White circles (“keratin pearls”)90.9%—
     Glomerular (coiled) vessels90.9%—
     Hairpin vessels78.8%—
     Rosettes75.8%—
    Actinic keratosis (level 1)
     Surface scale97.0%—
     Rosettes81.8%—
     Strawberry pattern (pink-red pseudonetwork ± fine wavy vessels [straight or coiled] surrounding  hair follicles ± white circles with central yellow clod [targetoid hair follicles])78.8%—
    Sebaceous hyperplasia (level 2)
     Pale yellow lobules (popcorn-like structures) around a central follicular opening100.0%—
     Crown vessels, out of focus90.9%—
    Pigmented actinic keratosis (level 2)
     Surface scale90.9%—
     Rosettes75.8%—
     Annular-granular pattern (gray dots around follicular openings)66.7%↓ 53.3%
     Red pseudonetwork†57.6%—
     Patent/evident follicles†57.6%—
    Squamous cell carcinoma in situ (level 2)
     Irregularly arranged glomerular (coiled)/dotted vessels93.9%—
     Surface scale87.9%—
    Keratoacanthoma (level 2)
     Central keratin mass93.9%—
     Hairpin (looped) or serpentine (linear-irregular) vessels, usually at the periphery, with white-yellow  halo87.9%—
    Angiokeratoma (level 2)
     Red/purple/black (“dark”) lacunae93.9%—
     Hemorrhagic crust75.8%—
    Lichen planus-like keratosis (level 2)
     Features of a lentigo or seborrheic keratosis in an area72.7%—
     Peppering (evenly spaced gray dots)69.7%↓ 63.3%
     Sharp cut-off borders (scalloped/moth-eaten)69.7%↓ 63.3%
     Coarse gray granularity63.6%↓ 53.3%
    Ink spot lentigo (level 2)
     Prominent dark homogenous (uniform) reticular network93.9%—
     Chicken-wire fence63.6%↓ 50.0%
    • ↵* % of panelists who indicated on a 5-point Likert scale that they “strongly agree” (5) or “agree” (4) with the feature being included in dermoscopy training for primary care providers.

    • ↵† Suggested by a panelist during round 1 of the features survey series.

    • Abbreviations: BCC, basal cell carcinoma; SCCIS, squamous cell carcinoma in situ (Bowen’s disease).

    • View popup
    Table 4.

    Dermoscopic Characteristics of Benign Melanocytic Lesions

    Diagnosis (Level 1 or 2)
    Feature included as a learning objective (>70% positive responses)
    Round 1: % Positive Responses* (n = 33)Round 2: % Positive Responses* (n = 30)
    Overview of benign nevi patterns (level 1)
     Diffuse reticular network100.0%—
     Peripheral reticular network with central hypopigmentation100.0%—
     Peripheral reticular network with central hyperpigmentation100.0%—
     Globular pattern100.0%—
     Patchy reticular network97.0%—
     Homogenous (tan, brown, blue, or pink)93.9%—
     Peripheral reticular network with central globules90.9%—
     Central network with evenly distributed peripheral globules87.9%—
     Symmetric multicomponent pattern75.8%—
     Symmetric two-component pattern69.7%↓ 60.0%
    Intradermal nevi (level 1)
     Comma-shaped (curved) vessels93.9%—
     Homogenous (structureless) brown/tan/pink pigmentation93.9%—
     Peripheral network72.7%—
     Globules87.9%—
    Blue nevi (level 2)
     Homogenous blue/blue-gray pigmentation100.0%—
     Well-circumscribed lesion93.9%—
    Spitz nevi (level 2)
     Starburst pattern with tiered globules/streaks and regularly spaced pseudopods at the periphery  (radial streaming)87.9%—
     Vascular pattern (pink homogenous with dotted vessels)75.8%—
    Congenital melanocytic nevi (level 2)
     Cobblestone pattern/globular pattern93.9%—
     Reticular network90.9%—
     Homogenous background pigmentation87.9%—
     Hypertrichosis78.8%—
     Perifollicular hyper-/hypopigmentation69.7%↓ 60.0%
    Recurrent/persistent nevi (level 2)
     Pigment within the scar, not extending beyond81.8%—
    Halo nevi (level 2)
     Encircling/surrounding depigmentation/pallor93.9%—
     Central reticulation with peripheral white depigmentation78.8%—
     Benign nevi patterns, globular, homogenous78.8%—
    • ↵* % of panelists who indicated on a 5-point Likert scale that they “strongly agree” (5) or “agree” (4) with the feature being included in dermoscopy training for primary care providers.

    • View popup
    Table 5.

    Dermoscopic Characteristics of Melanomas

    Diagnosis (Level 1 or 2)
    Feature included as a learning objective (>70% positive responses)
    Round 1: % Positive Responses* (n = 33)Round 2: % Positive Responses* (n = 30)
    Overview of melanoma patterns (level 1)
     Blue structures (blue-white veil, blue-gray structures)100.0%—
     Shiny white lines/structures (crystalline structures)100.0%—
     Atypical pigment network97.0%—
     Atypical/irregular streaks (radial streaming, pseudopods)97.0%—
     Atypical/irregular dots/globules93.9%—
     Regression structures (white scar-like area and/or peppering)93.9%—
     Negative pigment network87.9%—
     Atypical vascular pattern/structures, polymorphous vessels (2 + types of blood vessels)87.9%—
     Peripheral brown/tan structureless area78.8%—
     Angulated lines (extrafacial)/polygons/zig-zag pattern75.8%—
     Atypical/off-center blotch(es)69.7%↑ 90.0%
    Acral melanoma (level 2)
     Parallel ridge pattern93.9%—
     Ulceration90.9%—
     Irregular diffuse pigmentation or blotch84.8%—
     Multicomponent pattern, asymmetry of structures/colors84.8%—
     Atypical fibrillar pattern72.7%—
     Neovascularization, milky red72.7%—
    Lentigo maligna melanoma (level 2)
     Annular-granular pattern (gray dots around follicular openings)90.9%—
     Asymmetric pigmentation around follicular openings/asymmetric follicular openings87.9%—
     Rhomboidal structures (angulated lines)/zig-zag pattern81.8%—
     Dark blotches ± obliterated hair follicles75.8%—
     Circle within a circle (isobar)60.6%↓ 56.7%
    Melanoma of the nail (level 2)
     Pigmentation of periungual skin (micro-Hutchinson's sign)90.9%—
     Triangular shape of pigment band (band diameter wider at proximal end)87.9%—
     Longitudinal brown/black broken lines with irregular spacing, width, coloration, or parallelism81.8%—
     Band width >3 mm or two thirds of nail plate width78.8%—
     Brown to black dots/globules associated with longitudinal lines60.6%↓ 50.0%
    Amelanotic/hypomelanotic melanoma (level 2)
     Milky red areas81.8%—
     Shiny white lines (crystalline structures)81.8%—
     Atypical vascular pattern, polymorphous vessels (2 + types of blood vessels)81.8%—
     Scar-like depigmentation75.8%—
    • ↵* % of panelists who indicated on a 5-point Likert scale that they “strongly agree” (5) or “agree” (4) with the feature being included in dermoscopy training for primary care providers.

    • View popup
    Table 6.

    Dermoscopic Characteristics of Benign Diagnoses at Special Sites

    Diagnosis (Level 1 or 2)
    Feature included as a learning objective (>70% positive responses)
    Round 1: % Positive Responses* (n = 33)Round 2: % Positive Responses* (n = 30)
    Subungual hemorrhage (level 1)
     Well-circumscribed red-black dots or blotches/blood spots90.9%—
     Discontiguous with the cuticle (not connected to the proximal nailfold or edge of nail)87.9%—
     Distal streaks of red-brown coloration (“filamentous” distal end)81.8%—
     Homogenous red/purple/black coloration without melanin granules69.7%↓ 60.0%
    Dermoscopic features of the face (level 2)
     Pseudonetwork78.8%—
    Benign patterns of acral nevi (level 2)
     Parallel furrow pattern (with pattern variations including single line, double line, single dotted line,  double dotted line)93.9%—
     Lattice-like pattern87.9%—
     Fibrillar pattern (soles only)84.8%—
     Homogenous pattern75.8%—
     Peas-in-a-pod pattern (parallel furrow + globules on ridges) (acral congenital melanocytic  nevi)69.7%↓ 56.7%
    Nevus of the nail (level 2)
     Uniform band thickness, color, and spacing with parallel band configuration and unbroken lines87.9%—
     Homogenous brown background coloration84.8%—
    Lentigo of the nail (level 2)
     Homogenous gray band or lines ± gray background78.8%—
     Regular light-brown lines†—60.0%
    Talon noir (level 2)
     Homogenous red-brown coloration78.8%—
     Cracks (lightning bolt sign)‡51.5%—
    • ↵* % of panelists who indicated on a 5-point Likert scale that they “strongly agree” (5) or “agree” (4) with the feature being included in dermoscopy training for primary care providers.

    • ↵† Suggested by a panelist during round 1 of the dermoscopic features survey series.

    • ‡ Feature did not undergo a revote in round 2 due to original threshold criteria for a revote being <70% but >60% positive responses.

    • View popup
    Table 7.

    Dermoscopic Characteristics of Other Diagnoses, Including Skin Infections and Infestations

    Diagnosis (Level 1 or 2)
    Feature included as a learning objective (>70% positive responses)
    Round 1: % Positive Responses* (n = 33)Round 2: % Positive Responses* (n = 30)
    Verruca (level 1)
    Papilliform structures93.9%—
    Tiny red-black dots (papillary capillaries)90.9%—
    Scabies (level 1)
    Delta-wing jet with contrail sign (small dark brown triangular structure located at the end of whitish structureless curved/wavy lines)90.9%—
    Molluscum contagiosum (level 2)
    Central pore or umbilication93.9%—
    Polylobular white-yellow amorphous structures81.8%—
    Linear or branched vessels (red corona)/crown vessels63.6%↓ 63.3%
    Radiation tattoo (level 2)
    Homogenous blue or black coloration84.8%—
    Scars (level 2)
    White depigmentation72.7%—
    Venous lake (level 2)
    Homogenous purple/blue/red coloration ± globules/clods93.9%—
    Psoriasis (level 2)
    Red or pink color with white scales/light-red background75.8%—
    Dotted vessels in a regular distribution72.7%—
    • ↵* % of panelists who indicated on a 5-point Likert scale that they “strongly agree” (5) or “agree” (4) with the feature being included in dermoscopy training for primary care providers.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 36 (1)
The Journal of the American Board of Family Medicine
Vol. 36, Issue 1
January/February 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
Tiffaney Tran, Peggy R. Cyr, Alex Verdieck, Miranda D. Lu, Hadjh T. Ahrns, Elizabeth G. Berry, William Bowen, Ralph P. Braun, Joshua M. Cusick-Lewis, Hung Q. Doan, Valerie L. Donohue, Deborah R. Erlich, Laura K. Ferris, Evelyne Harkemanne, Rebecca I. Hartman, James Holt, Natalia Jaimes, Timothy A. Joslin, Zhyldyz Kabaeva, Tracey N. Liebman, Joanna Ludzik, Ashfaq A. Marghoob, Isac Simpson, Jennifer A. Stein, Daniel L. Stulberg, Isabelle Tromme, Matthew J. Turnquist, Richard P. Usatine, Alison M. Walker, Bryan L. Walker, Robert F. West, Megan L. Wilson, Alexander Witkowski, Dominic J. Wu, Elizabeth V. Seiverling, Kelly C. Nelson
The Journal of the American Board of Family Medicine Feb 2023, 36 (1) 25-38; DOI: 10.3122/jabfm.2022.220143R1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
Tiffaney Tran, Peggy R. Cyr, Alex Verdieck, Miranda D. Lu, Hadjh T. Ahrns, Elizabeth G. Berry, William Bowen, Ralph P. Braun, Joshua M. Cusick-Lewis, Hung Q. Doan, Valerie L. Donohue, Deborah R. Erlich, Laura K. Ferris, Evelyne Harkemanne, Rebecca I. Hartman, James Holt, Natalia Jaimes, Timothy A. Joslin, Zhyldyz Kabaeva, Tracey N. Liebman, Joanna Ludzik, Ashfaq A. Marghoob, Isac Simpson, Jennifer A. Stein, Daniel L. Stulberg, Isabelle Tromme, Matthew J. Turnquist, Richard P. Usatine, Alison M. Walker, Bryan L. Walker, Robert F. West, Megan L. Wilson, Alexander Witkowski, Dominic J. Wu, Elizabeth V. Seiverling, Kelly C. Nelson
The Journal of the American Board of Family Medicine Feb 2023, 36 (1) 25-38; DOI: 10.3122/jabfm.2022.220143R1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Appendices.
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Re: Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
  • Thinking and Practicing Thoughtfully and Thoroughly
  • Response: Re: Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
  • Family Physicians Can/Should Do: What? Where? And How?
  • Google Scholar

More in this TOC Section

  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
Show more Original Research

Similar Articles

Keywords

  • Continuing Medical Education
  • Delphi Method
  • Dermoscopy
  • Expert Opinion
  • Focus Groups
  • General Practitioners
  • Melanoma
  • Primary Care Physicians
  • Primary Health Care
  • Skin Cancer

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire